Ka‐Wai Wan

1.4k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Ka‐Wai Wan is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Ka‐Wai Wan has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Biomaterials and 5 papers in Biomedical Engineering. Recurrent topics in Ka‐Wai Wan's work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (6 papers) and Advancements in Transdermal Drug Delivery (3 papers). Ka‐Wai Wan is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (6 papers) and Advancements in Transdermal Drug Delivery (3 papers). Ka‐Wai Wan collaborates with scholars based in United Kingdom, Qatar and China. Ka‐Wai Wan's co-authors include Mohamed A. Alhnan, Basel Arafat, Tochukwu C. Okwuosa, Waqar Ahmed, Muzna Sadia, Abdullah Isreb, Abdelbary Elhissi, Gary P. Moss, Jon R. Heylings and David A. Phoenix and has published in prestigious journals such as Biomacromolecules, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Ka‐Wai Wan

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emergence of 3D Printed Dosage Forms: Opportunities and Challenges

2016 412 citations Mohamed A. Alhnan, Tochukwu C. Okwuosa et al. Pharmaceutical Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ka‐Wai Wan United Kingdom	16	674	471	209	185	174	19	1.1k
C. Branford-White United Kingdom	13	495 0.7×	218 0.5×	172 0.8×	481 2.6×	116 0.7×	42	1.1k
Joanna Szafraniec-Szczęsny Poland	19	745 1.1×	538 1.1×	91 0.4×	191 1.0×	387 2.2×	38	1.4k
Mohammad Isreb United Kingdom	12	504 0.7×	338 0.7×	127 0.6×	152 0.8×	195 1.1×	30	912
Dinesh Nyavanandi United States	19	368 0.5×	200 0.4×	304 1.5×	266 1.4×	522 3.0×	31	1.3k
Janitha M. Unagolla United States	10	578 0.9×	222 0.5×	104 0.5×	318 1.7×	151 0.9×	13	1.0k
Himanshu Kathuria Singapore	19	467 0.7×	237 0.5×	223 1.1×	183 1.0×	550 3.2×	38	1.3k
Ruzica Kolakovic Finland	17	428 0.6×	209 0.4×	82 0.4×	510 2.8×	212 1.2×	21	1.2k
Qingliang Yang China	21	413 0.6×	104 0.2×	202 1.0×	207 1.1×	405 2.3×	66	1.3k
Christopher J. Branford‐White United Kingdom	16	320 0.5×	100 0.2×	223 1.1×	451 2.4×	62 0.4×	26	990
Iordana Neamţu Ukraine	15	339 0.5×	100 0.2×	105 0.5×	429 2.3×	138 0.8×	45	1.1k

Countries citing papers authored by Ka‐Wai Wan

Since Specialization

Citations

This map shows the geographic impact of Ka‐Wai Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ka‐Wai Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ka‐Wai Wan more than expected).

Fields of papers citing papers by Ka‐Wai Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ka‐Wai Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ka‐Wai Wan. The network helps show where Ka‐Wai Wan may publish in the future.

Co-authorship network of co-authors of Ka‐Wai Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Ka‐Wai Wan. A scholar is included among the top collaborators of Ka‐Wai Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ka‐Wai Wan. Ka‐Wai Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Alhnan, Mohamed A., et al.. (2021). The Potential of Nanotherapeutics to Target Brain Tumors: Current Challenges and Future Opportunities. Nanomedicine. 16(21). 1833–1837. 4 indexed citations

Alhnan, Mohamed A., et al.. (2020). RGD-Decorated Solid Lipid Nanoparticles Enhance Tumor Targeting, Penetration and Anticancer Effect of Asiatic Acid. Nanomedicine. 15(16). 1567–1583. 41 indexed citations

Wang, Qin, Ka‐Wai Wan, Waqar Ahmed, et al.. (2019). Liposome mediated-CYP1A1 gene silencing nanomedicine prepared using lipid film-coated proliposomes as a potential treatment strategy of lung cancer. International Journal of Pharmaceutics. 566. 185–193. 16 indexed citations

Holmes, Amy, Jon R. Heylings, Ka‐Wai Wan, & Gary P. Moss. (2018). Antimicrobial efficacy and mechanism of action of poly(amidoamine) (PAMAM) dendrimers against opportunistic pathogens. International Journal of Antimicrobial Agents. 53(4). 500–507. 37 indexed citations

Wan, Ka‐Wai, et al.. (2017). Improved transdermal delivery of morin efficiently inhibits allergic contact dermatitis. International Journal of Pharmaceutics. 530(1-2). 145–154. 10 indexed citations

Holmes, Amy, David J. Scurr, Jon R. Heylings, Ka‐Wai Wan, & Gary P. Moss. (2017). Dendrimer pre-treatment enhances the skin permeation of chlorhexidine digluconate: Characterisation by in vitro percutaneous absorption studies and Time-of-Flight Secondary Ion Mass Spectrometry. European Journal of Pharmaceutical Sciences. 104. 90–101. 17 indexed citations

Wan, Ka‐Wai, et al.. (2017). Pharmacological effects of asiatic acid in glioblastoma cells under hypoxia. Molecular and Cellular Biochemistry. 430(1-2). 179–190. 25 indexed citations

Alhnan, Mohamed A., Tochukwu C. Okwuosa, Muzna Sadia, et al.. (2016). Emergence of 3D Printed Dosage Forms: Opportunities and Challenges. Pharmaceutical Research. 33(8). 1817–1832. 412 indexed citations breakdown →

Alhnan, Mohamed A., et al.. (2016). Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles. International Journal of Pharmaceutics. 500(1-2). 305–315. 70 indexed citations

10.

Okwuosa, Tochukwu C., et al.. (2016). A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Pharmaceutical Research. 33(11). 2704–2712. 220 indexed citations

11.

Najlah, Mohammad, Ka‐Wai Wan, Waqar Ahmed, et al.. (2016). Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells. Journal of Liposome Research. 28(1). 74–85. 22 indexed citations

12.

Najlah, Mohammad, et al.. (2016). Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines. International Journal of Pharmaceutics. 506(1-2). 102–109. 40 indexed citations

13.

Fan, Minmin, Abdelbary Elhissi, Zhirong Zhang, et al.. (2015). PEGylated Graphene Oxide for Tumor-Targeted Delivery of Paclitaxel. Nanomedicine. 10(8). 1247–1262. 61 indexed citations

14.

Wu, Chengyu, Zhirong Zhang, Ka‐Wai Wan, et al.. (2014). Thymopentin Nanoparticles Engineered with High Loading Efficiency, Improved Pharmacokinetic Properties, and Enhanced Immunostimulating Effect Using Soybean Phospholipid and PHBHHx Polymer. Molecular Pharmaceutics. 11(10). 3371–3377. 24 indexed citations

15.

Najlah, Mohammad, Ka‐Wai Wan, Waqar Ahmed, et al.. (2013). Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature. Pharmaceutical Development and Technology. 19(8). 999–1004. 21 indexed citations

16.

Moss, Gary P., et al.. (2013). Optical coherence tomography to delineate the interactions of PAMAM dendrimers with the porcine skin surface. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 8580. 85800G–85800G. 2 indexed citations

17.

Scurr, David J., et al.. (2013). Distribution and Visualisation of Chlorhexidine Within the Skin Using ToF-SIMS: A Potential Platform for the Design of More Efficacious Skin Antiseptic Formulations. Pharmaceutical Research. 30(7). 1896–1905. 35 indexed citations

18.

Griffiths, Peter C., Alison Paul, Ka‐Wai Wan, et al.. (2004). Understanding the Mechanism of Action of Poly(amidoamine)s as Endosomolytic Polymers: Correlation of Physicochemical and Biological Properties. Biomacromolecules. 5(4). 1422–1427. 52 indexed citations

19.

Wan, Ka‐Wai, Beatrice Malgesini, Paolo Ferruti, et al.. (2004). Poly(amidoamine) Salt Form: Effect on pH-Dependent Membrane Activity and Polymer Conformation in Solution. Biomacromolecules. 5(3). 1102–1109. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact